Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 18:17:04 UTC |
---|
Update Date | 2021-09-26 23:13:39 UTC |
---|
HMDB ID | HMDB0257350 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid |
---|
Description | 4-(2-{[1-({[1,1'-biphenyl]-4-yl}methyl)-2-oxoazepan-3-yl]-C-hydroxycarbonimidoyl}-2-[(1-hydroxyethylidene)amino]ethyl)-2-formylbenzoic acid belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Based on a literature review very few articles have been published on 4-(2-{[1-({[1,1'-biphenyl]-4-yl}methyl)-2-oxoazepan-3-yl]-C-hydroxycarbonimidoyl}-2-[(1-hydroxyethylidene)amino]ethyl)-2-formylbenzoic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). 4-[2-acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC(=O)NC(CC1=CC(C=O)=C(C=C1)C(O)=O)C(=O)NC1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O InChI=1S/C32H33N3O6/c1-21(37)33-29(18-23-12-15-27(32(40)41)26(17-23)20-36)30(38)34-28-9-5-6-16-35(31(28)39)19-22-10-13-25(14-11-22)24-7-3-2-4-8-24/h2-4,7-8,10-15,17,20,28-29H,5-6,9,16,18-19H2,1H3,(H,33,37)(H,34,38)(H,40,41) |
---|
Synonyms | Value | Source |
---|
4-(2-{[1-({[1,1'-biphenyl]-4-yl}methyl)-2-oxoazepan-3-yl]-C-hydroxycarbonimidoyl}-2-[(1-hydroxyethylidene)amino]ethyl)-2-formylbenzoate | Generator | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoate | Generator |
|
---|
Chemical Formula | C32H33N3O6 |
---|
Average Molecular Weight | 555.631 |
---|
Monoisotopic Molecular Weight | 555.236935795 |
---|
IUPAC Name | 4-(2-{[1-({[1,1'-biphenyl]-4-yl}methyl)-2-oxoazepan-3-yl]carbamoyl}-2-acetamidoethyl)-2-formylbenzoic acid |
---|
Traditional Name | 4-{2-[(1-{[1,1'-biphenyl]-4-ylmethyl}-2-oxoazepan-3-yl)carbamoyl]-2-acetamidoethyl}-2-formylbenzoic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC(=O)NC(CC1=CC(C=O)=C(C=C1)C(O)=O)C(=O)NC1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=O |
---|
InChI Identifier | InChI=1S/C32H33N3O6/c1-21(37)33-29(18-23-12-15-27(32(40)41)26(17-23)20-36)30(38)34-28-9-5-6-16-35(31(28)39)19-22-10-13-25(14-11-22)24-7-3-2-4-8-24/h2-4,7-8,10-15,17,20,28-29H,5-6,9,16,18-19H2,1H3,(H,33,37)(H,34,38)(H,40,41) |
---|
InChI Key | WKTQBTSOHBKBRW-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Dipeptides |
---|
Alternative Parents | |
---|
Substituents | - Alpha-dipeptide
- Phenylalanine or derivatives
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Biphenyl
- N-substituted-alpha-amino acid
- Alpha-amino acid or derivatives
- Amphetamine or derivatives
- Benzoic acid or derivatives
- Benzoic acid
- Benzaldehyde
- Benzoyl
- Caprolactam
- Azepane
- Aryl-aldehyde
- Monocyclic benzene moiety
- Fatty acyl
- Benzenoid
- Fatty amide
- Tertiary carboxylic acid amide
- Acetamide
- Carboxamide group
- Lactam
- Secondary carboxylic acid amide
- Carboxylic acid
- Azacycle
- Organoheterocyclic compound
- Organonitrogen compound
- Aldehyde
- Organic nitrogen compound
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Organooxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 218.737 | 30932474 | DeepCCS | [M-H]- | 216.341 | 30932474 | DeepCCS | [M-2H]- | 249.226 | 30932474 | DeepCCS | [M+Na]+ | 224.649 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TMS,isomer #1 | CC(=O)N(C(CC1=CC=C(C(=O)O[Si](C)(C)C)C(C=O)=C1)C(=O)NC1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C | 4646.5 | Semi standard non polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TMS,isomer #1 | CC(=O)N(C(CC1=CC=C(C(=O)O[Si](C)(C)C)C(C=O)=C1)C(=O)NC1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C | 4784.0 | Standard non polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TMS,isomer #1 | CC(=O)N(C(CC1=CC=C(C(=O)O[Si](C)(C)C)C(C=O)=C1)C(=O)NC1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C | 6298.2 | Standard polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TMS,isomer #2 | CC(=O)NC(CC1=CC=C(C(=O)O[Si](C)(C)C)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C | 4661.4 | Semi standard non polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TMS,isomer #2 | CC(=O)NC(CC1=CC=C(C(=O)O[Si](C)(C)C)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C | 4677.0 | Standard non polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TMS,isomer #2 | CC(=O)NC(CC1=CC=C(C(=O)O[Si](C)(C)C)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C | 6212.0 | Standard polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TMS,isomer #3 | CC(=O)N(C(CC1=CC=C(C(=O)O)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C)[Si](C)(C)C | 4604.4 | Semi standard non polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TMS,isomer #3 | CC(=O)N(C(CC1=CC=C(C(=O)O)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C)[Si](C)(C)C | 4789.8 | Standard non polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TMS,isomer #3 | CC(=O)N(C(CC1=CC=C(C(=O)O)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C)[Si](C)(C)C | 6240.4 | Standard polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,3TMS,isomer #1 | CC(=O)N(C(CC1=CC=C(C(=O)O[Si](C)(C)C)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C)[Si](C)(C)C | 4533.4 | Semi standard non polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,3TMS,isomer #1 | CC(=O)N(C(CC1=CC=C(C(=O)O[Si](C)(C)C)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C)[Si](C)(C)C | 4725.4 | Standard non polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,3TMS,isomer #1 | CC(=O)N(C(CC1=CC=C(C(=O)O[Si](C)(C)C)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C)[Si](C)(C)C | 5896.8 | Standard polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TBDMS,isomer #1 | CC(=O)N(C(CC1=CC=C(C(=O)O[Si](C)(C)C(C)(C)C)C(C=O)=C1)C(=O)NC1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C(C)(C)C | 5091.3 | Semi standard non polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TBDMS,isomer #1 | CC(=O)N(C(CC1=CC=C(C(=O)O[Si](C)(C)C(C)(C)C)C(C=O)=C1)C(=O)NC1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C(C)(C)C | 5181.9 | Standard non polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TBDMS,isomer #1 | CC(=O)N(C(CC1=CC=C(C(=O)O[Si](C)(C)C(C)(C)C)C(C=O)=C1)C(=O)NC1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C(C)(C)C | 6236.2 | Standard polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TBDMS,isomer #2 | CC(=O)NC(CC1=CC=C(C(=O)O[Si](C)(C)C(C)(C)C)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C(C)(C)C | 5100.2 | Semi standard non polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TBDMS,isomer #2 | CC(=O)NC(CC1=CC=C(C(=O)O[Si](C)(C)C(C)(C)C)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C(C)(C)C | 5068.2 | Standard non polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TBDMS,isomer #2 | CC(=O)NC(CC1=CC=C(C(=O)O[Si](C)(C)C(C)(C)C)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C(C)(C)C | 6146.1 | Standard polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TBDMS,isomer #3 | CC(=O)N(C(CC1=CC=C(C(=O)O)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 5087.5 | Semi standard non polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TBDMS,isomer #3 | CC(=O)N(C(CC1=CC=C(C(=O)O)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 5197.7 | Standard non polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,2TBDMS,isomer #3 | CC(=O)N(C(CC1=CC=C(C(=O)O)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 6158.3 | Standard polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,3TBDMS,isomer #1 | CC(=O)N(C(CC1=CC=C(C(=O)O[Si](C)(C)C(C)(C)C)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 5172.6 | Semi standard non polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,3TBDMS,isomer #1 | CC(=O)N(C(CC1=CC=C(C(=O)O[Si](C)(C)C(C)(C)C)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 5276.7 | Standard non polar | 33892256 | 4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid,3TBDMS,isomer #1 | CC(=O)N(C(CC1=CC=C(C(=O)O[Si](C)(C)C(C)(C)C)C(C=O)=C1)C(=O)N(C1CCCCN(CC2=CC=C(C3=CC=CC=C3)C=C2)C1=O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 5862.3 | Standard polar | 33892256 |
|
---|